We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Diagnostics

DB function failed with error number 0

AI Tool Predicts Bevacizumab Non-Response in Metastatic Colorectal Cancer

More...
15 Apr 2026
Image: The PrepQuant System is assay-agnostic and generates highly concentrated genomic DNA and cfDNA suitable for NGS, qPCR and dPCRassays (photo courtesy of 123RF)

Automated Sample Preparation System Standardizes Pre-Analytical Workflow for MRD and Liquid Biopsy

A new system unifies extraction, concentration, and quantification to standardize pre-analytical workflows and cut variability. More...
15 Apr 2026
Image: Dengue is among the most widespread mosquito-borne infections, yet early risk stratification can be difficult when symptoms overlap with other febrile illnesses (photo courtesy of Adobe Stock)

Urine-Based Assay Predicts Severe Dengue Risk Early

A new urine test measures two inflammation-associated proteins to predict severe dengue earlier, outperforming warning signs to guide triage. More...
14 Apr 2026
Image: Elecsys NfL is an in vitro quantitative immunoassay that measures neurofilament light chain protein concentrations in human serum and plasma (photo courtesy of Roche)

CE-Marked Blood Test Enables Monitoring of Neuroinflammation in Multiple Sclerosis

Roche’s Elecsys Neurofilament Light Chain (NfL) test has received CE mark approval for use in adults diagnosed with relapsing‑remitting multiple sclerosis (RRMS). More...
14 Apr 2026
Image: Personalis’ NeXT Personal ultrasensitive ctDNA assay will be featured alongside the debut of Real‑Time Variant Tracker at the AACR Annual Meeting 2026 in San Diego (photo courtesy of Personalis)

Ultrasensitive Assay Tracks Resistance Mutations MRD Monitoring

A new ctDNA MRD test tracks resistance mutations and detects down to 10 ppm to predict immunotherapy response and relapse. More...
14 Apr 2026
Image: This diagram outlines the dual potential of EV-RNAs in IBD: as non-invasive biomarkers for early diagnosis and monitoring, and as carriers of regulatory RNAs to target inflammation, repair the epithelial barrier, and restore gut homeostasis. (Ruizhe Ren/Zhejiang Chinese Medical University, Xiyang Wei/Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine)

Extracellular Vesicle RNA Biomarkers Enable Noninvasive IBD Diagnosis and Monitoring

EV‑RNA biomarkers show promise for noninvasive monitoring and treatment of inflammatory bowel disease. More...
13 Apr 2026
Image: A prescription kit is mailed directly to a patient’s home for self-collection, with the specimen then returned by mail to a laboratory for processing. (photo courtesy of BD)

FDA Clears At-Home HPV Test with Extended Genotyping for Cervical Screening

A new at-home HPV self-collection kit and extended genotyping assay enable mail-in clinician-ordered cervical screening. More...
13 Apr 2026
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Thyroid Test
Anti-Thyroid EIA Test
New
Repetitive Pipette
VWR® Stepper Pro


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.